@misc{indiciaed136677dc6e4,
  title = {The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters},
  author = {Miorin, L. and Mire, C. E. and Ranjbar, S. and Hume, A. J. and Huang, J. and Crossland, N. A. and White, K. M. and Laporte, M. and Kehrer, T. and Haridas, V. and Moreno, E. and Nambu, A. and Jangra, S. and Cupic, A. and Dejosez, M. and Abo, K. A. and Tseng, A. E. and Werder, R. B. and Rathnasinghe, R. and Mutetwa, T. and Ramos, I. and Sainz de Aja, J. and Garcia de Alba Rivas, C. and Schotsaert, M. and Corley, R. B. and Falvo, J. V. and Fernandez-Sesma, A. and Kim, C. and Rossignol, J.-F. and Wilson, A. A. and Zwaka, T. and Kotton, D. N. and Mühlberger, E. and García-Sastre, A. and Goldfeld, A. E.},
  year = {2022},
  doi = {10.1101/2022.02.08.479634},
  url = {https://www.biorxiv.org/content/10.1101/2022.02.08.479634v1},
  note = {Source identifier: 10.1101/2022.02.08.479634}
}